PULMATRIX, INC. Accretion of Discount (Deprecated 2016-01-31)
PULMATRIX, INC. (PULM) reported Accretion of Discount (Deprecated 2016-01-31) of $26.00 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-05.
Discontinued › Notes
us-gaap:AccretionOfDiscount · last filed 2016-05-05
- PULMATRIX, INC. accretion of discount (deprecated 2016-01-31) for the quarter ending 2016-03-31 was $26.00K, a 98.18% decline year-over-year.
- PULMATRIX, INC. accretion of discount (deprecated 2016-01-31) for the quarter ending 2015-03-31 was $1.43M.
| Period end | Accretion of Discount (Deprecated 2016-01-31) 3 month |
|---|---|
| 2016-03-31 | $26.00K 10-Q · filed 2016-05-05 |
| 2015-03-31 | $1.43M 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |